tm
Seeing Is Believing
tm
Seeing Is Believing
Y mAbs Therapeutics's activity chart (see below) currently has 103 price targets and 81 ratings on display.
Analysts average stock forecasts to be materialized ratio is 32.52% with an average time for these price targets to be met of 87.25 days.
Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 06-Aug-2025. First documented stock forecast 16-Oct-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jan-2020
$8.6
$-0.01 (-0.12%)
$11
1 years 2 months 25 days ago
(06-Aug-2025)
5/12 (41.67%)
$0.08 (0.94%)
140
Buy Since 16-Aug-2024
$8.6
$-0.01 (-0.12%)
$19
1 years 2 months 26 days ago
(05-Aug-2025)
1/4 (25%)
$0.08 (0.94%)
41
Buy Since 28-Jun-2024
$8.6
$-0.01 (-0.12%)
$14
1 years 2 months 26 days ago
(05-Aug-2025)
1/4 (25%)
$0.08 (0.94%)
41
Buy Since 11-Jul-2024
$18
1 years 2 months 26 days ago
(05-Aug-2025)
0/2 (0%)
$13.15 (271.13%)
Sell Since 10-May-2023
$8.6
$-0.01 (-0.12%)
$7
1 years 2 months 26 days ago
(05-Aug-2025)
4/5 (80%)
$0.08 (0.94%)
108
What is YMAB (Y mAbs Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on YMAB (Y mAbs Therapeutics)?
Which analyst has the most public recommendations on YMAB (Y mAbs Therapeutics)?
Which analyst is the currently most bullish on YMAB (Y mAbs Therapeutics)?
Which analyst is the currently most reserved on YMAB (Y mAbs Therapeutics)?
